Sermika 100 Injection is a commercial drug that is prescribed in the form of Injection. Primarily, it is used for the treatment of Urinary Tract Infection. Sermika 100 Injection also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Sermika 100 Injection. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Some other side effects of Sermika 100 Injection have been listed ahead. Usually, these side effects of Sermika 100 Injection go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Sermika 100 Injection is Severe for pregnant women and Unknown for women who are breastfeeding. It is important to know if Sermika 100 Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Sermika 100 Injection related warnings section.
Sermika 100 Injection is contraindicated in people with pre-existing medical conditions like Dehydration, Parkinson's Disease, Hearing Loss as it can result in adverse effects. The section on Sermika 100 Injection contraindications lists all such conditions.
Besides this, Sermika 100 Injection may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Sermika 100 Injection is safe while driving, and is is addictive in nature.
Sermika 100 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Sermika 100 Injection is used -
Moderate
Mild
Unknown
Is the use of Sermika 100 Injection safe for pregnant women?
Sermika shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Sermika 100 Injection safe during breastfeeding?
There is no research available on the side effects of Sermika in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Sermika 100 Injection on the Kidneys?
Sermika may have severe effects on your kidney, so do not take it without consulting your doctor.
What is the effect of Sermika 100 Injection on the Liver?
Very few cases of side effects of Sermika on the liver have been reported.
What is the effect of Sermika 100 Injection on the Heart?
Side effects of Sermika rarely affect the heart.
Sermika 100 Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Sermika 100 Injection unless your doctor advises you to do so -
Is this Sermika 100 Injection habit forming or addictive?
Sermika 100 Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Sermika 100 Injection since it will not make you feel sleepy.
Is it safe?
Yes, but consume Sermika 100 Injection only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Sermika 100 Injection for mental disorders.
Interaction between Food and Sermika 100 Injection
Taking Sermika 100 Injection with food is safe.
Interaction between Alcohol and Sermika 100 Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Sermika 100 Injection.
Do not self-administer Sermika. It comes in the form of injection and given preferably 2 - 3 times in a day (Intravenously). Discontinuing the medicine in between may promote resistant bacteria which result in a relapse of the infection. You are recommended to complete the 7 - 10 days course even after getting symptomatic relief. In case you feel any discomfort such as hearing loss and nephrotoxicity while taking Sermika please inform your doctor immediately.
Yes, Sermika has been reported to cause ototoxicity (hearing loss or deafness) which is irreversible and may progress after discontinuation of the drug. It is a common side effect of this medicine. If you experience hearing loss or deafness after consuming or applying for this medicine, then consult your doctor and follow his/her instructions.
Sermika is a prescription drug, hence do not take Sermika without consulting doctor. It can be harmful to patients to take this medicine without a doctor's advice.
Sermika is a brand name for amikacin. It is a prescription drug which belongs to the class of medication known as an aminoglycoside antibiotic. It is a broad spectrum antibiotic which is used for the treatment of bacterial infection such as bone, joint, skin, intra-abdominal, pneumonia, and respiratory tract infection. It is used for short-term treatment (7 - 10 days) of bacterial infection in different part of the body. It is also used for the treatment of neonatal sepsis when sensitivity testing indicates that other aminoglycosides cannot be used.
Discontinuing Sermika on your own can increase the chances of bacterial resistance and infection relapse. It is recommended that you always consult your doctor if you have decided to discontinue this medicine.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137
